Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an East Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
#4 Risks Associated With Peptide Dosing Safety: Giving too much can trigger immune reactions, or too little can reduce effectiveness
Thinking about a GLP-1 for weight loss
The GIP receptor activation in tirzepatide appears to moderate the gastrointestinal effects of GLP-1 receptor activation
When people feel better, they tend to miss fewer days at work, stay more focused, and engage more with their teams
Expertly formulated for everyday skincare, this lightweight facial serum delivers long-lasting hydration while helping support your skin's natural moisture b